Variant report
Variant | esv19425 |
---|---|
Chromosome Location | chr8:47545887-47563212 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533920785 | chr8:47547437-47547438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574290932 | chr8:47547458-47547459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138660810 | chr8:47547463-47547464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78890361 | chr8:47547490-47547491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367919571 | chr8:47547528-47547529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542467108 | chr8:47547533-47547534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554597059 | chr8:47547547-47547548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559893948 | chr8:47547619-47547620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575794980 | chr8:47547639-47547640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545107220 | chr8:47547652-47547653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141173301 | chr8:47547693-47547694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527313848 | chr8:47547733-47547734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73572803 | chr8:47547743-47547744 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs150318802 | chr8:47547744-47547745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs180997646 | chr8:47547801-47547802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529618864 | chr8:47547803-47547804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs386725019 | chr8:47547812-47547813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187167335 | chr8:47547814-47547815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531783565 | chr8:47547825-47547826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192094586 | chr8:47547838-47547839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571635700 | chr8:47547858-47547859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149502308 | chr8:47547863-47547864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553751419 | chr8:47547872-47547873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567281587 | chr8:47547919-47547920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116430612 | chr8:47547937-47547938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541103216 | chr8:47547946-47547947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs117364137 | chr8:47547963-47547964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575857937 | chr8:47547969-47547970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532732922 | chr8:47547980-47547981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544859213 | chr8:47547982-47547983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553982008 | chr8:47548061-47548062 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182154612 | chr8:47548148-47548149 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186828637 | chr8:47548158-47548159 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541076378 | chr8:47548180-47548181 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371752003 | chr8:47548190-47548191 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146003744 | chr8:47548196-47548197 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139950074 | chr8:47548269-47548270 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74543047 | chr8:47548299-47548300 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373659441 | chr8:47548391-47548392 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563154520 | chr8:47548399-47548400 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531968359 | chr8:47548433-47548434 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs369009583 | chr8:47548461-47548462 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549675405 | chr8:47548483-47548484 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190711027 | chr8:47548519-47548520 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527791905 | chr8:47548629-47548630 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182627934 | chr8:47548634-47548635 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187327561 | chr8:47548656-47548657 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567341430 | chr8:47548695-47548696 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557696789 | chr8:47548711-47548712 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536221074 | chr8:47548729-47548730 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Oral cancer | 21386901 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:47547400-47549400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
2 | chr8:47547400-47549600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
3 | chr8:47548000-47549200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr8:47549400-47554800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr8:47549600-47555000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
6 | chr8:47554800-47555600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
7 | chr8:47555000-47556600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
8 | chr8:47555600-47560600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
9 | chr8:47556600-47560600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
10 | chr8:47560600-47564400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr8:47560600-47564400 | Enhancers | Skeletal Muscle Female | skeletal muscle |